Continuing testing of the first diabetes drug

Researchers at Mount Sinai Hospital in New York continue to test the drug mix, which can increase the number of insulin-producing cells.

This association could become the first medicine in the history of medicine to treat diabetes drastically.

Scientists have discovered that the new drug, called Harmine, can act as a "turbocharger" for pancreatic cells, producing insulin 10 times more than beta cells a day.

When administered with another bone growth stimulating drug, the amount of insulin produced by beta cells was multiplied by 40 by 40.

The drug is still undergoing various tests, but scientists believe that this powerful effect on beta cells could radically change everything related to the treatment of patients with type I or type II diabetes.